本期我們關(guān)注一種常見病原體水痘-帶狀皰疹病毒導(dǎo)致的疾病-帶狀皰疹，了解目前的疾病負(fù)擔(dān)和疫苗研發(fā)進(jìn)展。

帶狀皰疹的疾病負(fù)擔(dān)有多大？

帶狀皰疹（herpes zoster, HZ）是由長期潛伏在脊髓后根神經(jīng)節(jié)或顱神經(jīng)節(jié)內(nèi)的水痘-帶狀皰疹病毒（varicella-zoster virus，VZV）經(jīng)再激活引起的感染性皮膚病。

帶狀皰疹是皮膚科常見病，除皮膚損害外，常伴有神經(jīng)病理性疼痛，多見于年齡較大、免疫抑制或免疫功能缺陷等人群，該疾病嚴(yán)重影響患者生活質(zhì)量。

2025年7月，WHO發(fā)布的帶狀皰疹疫苗立場文件顯示：2020年全球≥50歲人群中新發(fā)1490萬例帶狀皰疹（herpes zoster, HZ)，預(yù)計到2030年，這一數(shù)字將升至1910萬。同時，HZ的終生患病率為30%，其帶來的帶狀皰疹后神經(jīng)痛（PHN）嚴(yán)重影響患者生活質(zhì)量，全球人口老齡化的進(jìn)展更是推動其疾病負(fù)擔(dān)不斷上升。

參考資料

·Mortimer KJ, Cruz AA, Sepúlveda-Pachón IT, Jorga A, Vroling H, Williams C. Global herpes zoster burden in adults with asthma: a systematic review and meta-analysis. Eur Respir J. 2024;64(2):2400462. Published 2024 Aug 8. doi:10.1183/13993003.00462-2024

·van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B. A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother. 2021;17(6):1714-1732. doi:10.1080/21645515.2020.1847582

·Zheng B, Yin D, Geng Y, et al. Herpes zoster incidence and burden in older Chinese: a systematic review and meta-analysis. BMC Public Health. 2025;25(1):1494. Published 2025 Apr 22. doi:10.1186/s12889-025-22703-6

·World Health Organization. WHO position paper on herpes zoster vaccines – July 2025. Wkly Epidemiol Rec. 2025;100(27-28):265-284. Published July 4, 2025. Accessed November 9, 2025. Available at:

https://www.nitag-resource.org/sites/default/files/2025-07/WER10027-28-265-284.pdf

·Recbio. Recbio Official Website. Published January 1, 2025. Accessed November 10, 2025.

https://www.recbio.cn/cn/media/press-release/20250101/?utm

·Sina Finance Technology. Sina Finance. Published June 9, 2025. Accessed November 10, 2025.

https://finance.sina.cn/tech/2025-06-09/detail-ineznxky4228132.d.html

·Synapse by Zhihuiya. CanSino Biotech’s shingles vaccine CS-2032 has been approved for clinical trials in Canada. Synapse Blog. Accessed November 10, 2025.

https://synapse-zhihuiya-com.libproxy1.nus.edu.sg/blog/concino-biotechs-shingles-vaccine-cs-2032-has-been-approved-for-clinical-trials-in-canada?utm

·Zhihuiya. Zhihuiya News. Accessed November 10, 2025. https://www.zhihuiya.com/news/info_8850.html?utm

·CNINFO. Published July 9, 2025. Accessed November 10, 2025. https://static.cninfo.com.cn/finalpage/2025-07-09/1224119373.PDF?utm

·Pharmcube BYDrug. Pharmcube. Accessed November 10, 2025. https://bydrug.pharmcube.com/news/detail/411ff2938154e52932e1d54cbe2b76e9

·Maxvax. Maxvax Official Website. Accessed November 10, 2025. https://www.maxvax.cn/info.aspx?id=119&t=9

·ByDrug (Pharmcube). 中科創(chuàng)星天使輪項目「深信生物」帶狀皰疹疫苗獲中國臨床試驗批準(zhǔn)｜創(chuàng)星Portfolio. ByDrug News. Published July 25, 2024. Accessed November 10, 2025. https://bydrug.pharmcube.com/news/detail/9e9bf6eaffe2af47837f5660780da347

·ByDrug (Pharmcube). 科興中維首款凍干帶狀皰疹病毒mRNA疫苗申報臨床！ ByDrug News. Published October 6, 2024. Accessed November 10, 2025. https://bydrug.pharmcube.com/news/detail/164da640f835d01a457ae044d591cd89

·RHEGEN Biotech. 全球首款凍干帶狀皰疹mRNA疫苗臨床試驗申請獲CDE批準(zhǔn). RHEGEN Company News. Published October 23, 2024. Accessed November 10, 2025.

https://www.rhegen.com/show-8-33-1.html

·Sinopharm Group. 國藥集團(tuán)中國生物首款帶狀皰疹mRNA疫苗獲批臨床. Sinopharm News Center. Published April 14, 2025. Accessed November 10, 2025.

https://www.sinopharm.com/2025-04/14/c_20034.htm

·ByDrug (Pharmcube). 艾美疫苗中美雙報迭代mRNA帶狀皰疹疫苗均獲批開展臨床. ByDrug News. Published May 21, 2025. Accessed November 10, 2025. https://bydrug.pharmcube.com/news/detail/ebd82600f32c179736a0bc3e995c4add

歡迎來到醫(yī)食參考新媒體矩陣

2023年疫苗接種攻略

陽過了，該怎么打疫苗？最全接種指導(dǎo)手冊來了

撰寫| CPIVC

校稿| Gddra編審| Hide / Blue sea

編輯 設(shè)計| Alice